John D. Lee

Array ( [id] => 8690177 [patent_doc_number] => 08389704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Binding members for IgE molecules' [patent_app_type] => utility [patent_app_number] => 12/527169 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 17 [patent_no_of_words] => 43730 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853430 [patent_doc_number] => 20080319173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Blood group antigen fusion polypeptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/011828 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14855 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0319/20080319173.pdf [firstpage_image] =>[orig_patent_app_number] => 12011828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585402 [patent_doc_number] => 20090104604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'SPERM-SPECIFIC CATION CHANNEL, CATSPER2, AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/021474 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23206 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104604.pdf [firstpage_image] =>[orig_patent_app_number] => 12021474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10837506 [patent_doc_number] => 08865179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Aptameric IgE peptides in a protein scaffold as an allergy vaccine' [patent_app_type] => utility [patent_app_number] => 12/011303 [patent_app_country] => US [patent_app_date] => 2008-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15426 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12011303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697794 [patent_doc_number] => 20080219978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Soluble FcgammaRIA and related methods' [patent_app_type] => utility [patent_app_number] => 12/011190 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 49783 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219978.pdf [firstpage_image] =>[orig_patent_app_number] => 12011190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8712848 [patent_doc_number] => 08398987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Use of platelet glycopeptide IIIa epitopes in the treatment of immune thrombocytopenic purpura' [patent_app_type] => utility [patent_app_number] => 12/523549 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7077 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12523549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948975 [patent_doc_number] => 20080305101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Methods and Compositions Related to Clot Binding Compounds' [patent_app_type] => utility [patent_app_number] => 11/967509 [patent_app_country] => US [patent_app_date] => 2007-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23738 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305101.pdf [firstpage_image] =>[orig_patent_app_number] => 11967509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577282 [patent_doc_number] => 08343491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Anti-HIMF antibodies to treat lung diseases' [patent_app_type] => utility [patent_app_number] => 12/518857 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 20 [patent_no_of_words] => 9038 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12518857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792142 [patent_doc_number] => 20080293116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'OVARY-SPECIFIC GENES AND PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/956641 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11310 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293116.pdf [firstpage_image] =>[orig_patent_app_number] => 11956641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314969 [patent_doc_number] => 20100112080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN' [patent_app_type] => utility [patent_app_number] => 12/518907 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 16116 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112080.pdf [firstpage_image] =>[orig_patent_app_number] => 12518907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7739520 [patent_doc_number] => 08105602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/001037 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 30637 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105602.pdf [firstpage_image] =>[orig_patent_app_number] => 12001037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726706 [patent_doc_number] => 20080206247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Glycoprotein VI fusion proteins' [patent_app_type] => utility [patent_app_number] => 11/987079 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8268 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206247.pdf [firstpage_image] =>[orig_patent_app_number] => 11987079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499499 [patent_doc_number] => 20100209947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Free human serum IgE immunoenzymetric assay and methods of use' [patent_app_type] => utility [patent_app_number] => 11/985350 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10002 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209947.pdf [firstpage_image] =>[orig_patent_app_number] => 11985350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764667 [patent_doc_number] => 20080175878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Protease for activating clotting factor VII' [patent_app_type] => utility [patent_app_number] => 11/984058 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9593 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175878.pdf [firstpage_image] =>[orig_patent_app_number] => 11984058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954526 [patent_doc_number] => 20080187550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Immunomodulatory Peptides Derived from Heat Shock Proteins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/938762 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16371 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187550.pdf [firstpage_image] =>[orig_patent_app_number] => 11938762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965974 [patent_doc_number] => 20080108794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER' [patent_app_type] => utility [patent_app_number] => 11/929221 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26552 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108794.pdf [firstpage_image] =>[orig_patent_app_number] => 11929221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484923 [patent_doc_number] => 20090274688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Antibodies to OPGL' [patent_app_type] => utility [patent_app_number] => 11/981664 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25831 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274688.pdf [firstpage_image] =>[orig_patent_app_number] => 11981664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4892966 [patent_doc_number] => 20080102064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein C Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/923770 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17167 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102064.pdf [firstpage_image] =>[orig_patent_app_number] => 11923770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820527 [patent_doc_number] => 20080226653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Inhibition of Platelet Aggregation' [patent_app_type] => utility [patent_app_number] => 11/875398 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8629 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226653.pdf [firstpage_image] =>[orig_patent_app_number] => 11875398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601112 [patent_doc_number] => 20100322921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR Va ANTIBODIES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/445864 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11761 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322921.pdf [firstpage_image] =>[orig_patent_app_number] => 12445864 [rel_patent_id] =>[rel_patent_doc_number] =>)